Works matching IS 11738804 AND DT 2011 AND VI 25 AND IP 3

Results: 8

Belimumab Efficacy is 'Mild' but Market Potential Still Great.

Published in:

BioDrugs, 2011, v. 25, n. 3, p. 203, doi. 10.2165/11591850-000000000-00000

By:

Weintraub, Ben

Publication type:

Article

Hot Ortho-Biologic Topics at AAOS 2011.

Published in:

BioDrugs, 2011, v. 25, n. 3, p. 197, doi. 10.2165/11592710-000000000-00000

By:

Hoggatt, Julie

Publication type:

Article

Temsirolimus in Relapsed and/or Refractory Mantle Cell Lymphoma.

Published in:

BioDrugs, 2011, v. 25, n. 3, p. 193, doi. 10.2165/11207050-000000000-00000

By:

Hoy, Sheridan M.;
McKeage, Kate

Publication type:

Article

Imatinib: As Adjuvant Therapy for Gastrointestinal Stromal Tumor.

Published in:

BioDrugs, 2011, v. 25, n. 3, p. 191, doi. 10.2165/11207040-000000000-00000

By:

Sanford, Mark;
Scott, Lesley J.

Publication type:

Article

Neovascular Age-Related Macular Degeneration.

Published in:

BioDrugs, 2011, v. 25, n. 3, p. 171, doi. 10.2165/11589330-000000000-00000

By:

Schiffelers, Raymond M.;
van der Vaart, Tjitske K.;
Storm, Gert

Publication type:

Article

Bevacizumab-Induced Hypertension.

Published in:

BioDrugs, 2011, v. 25, n. 3, p. 159, doi. 10.2165/11590180-000000000-00000

By:

Syrigos, Kostas N.;
Karapanagiotou, Eleni;
Boura, Paraskevi;
Manegold, Christian;
Harrin, Kevin

Publication type:

Article

Activity and Safety of Dasatinib as Second-Line Treatment or in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients.

Published in:

BioDrugs, 2011, v. 25, n. 3, p. 147, doi. 10.2165/11591840-000000000-00000

By:

Breccia, Massimo;
Alimena, Giuliana

Publication type:

Article

Erlotinib.

Published in:

BioDrugs, 2011, v. 25, n. 3, p. 139, doi. 10.2165/11206910-000000000-00000

By:

Muir, Victoria J.;
Dhillon, Sohita

Publication type:

Article